Skip to main content

Advertisement

SpringerLink
Log in

Perturbed Autonomic Nervous System Function in Metabolic Syndrome

  • Original Paper
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

Abstract

The metabolic syndrome is characterized by the clustering of various common metabolic abnormalities in an individual and it is associated with increased risk for the development of type 2 diabetes and cardiovascular diseases. Its prevalence in the general population is approximately 25%. Central fat accumulation and insulin resistance are considered as the common denominators of the abnormalities of the metabolic syndrome. Subjects with metabolic syndrome have autonomic nervous system dysfunction characterized by predominance of the sympathetic nervous system in many organs, i.e. heart, kidneys, vasculature, adipose tissue, and muscles. Sympathetic nervous system activation in metabolic syndrome is detected as increased heart rate and blood pressure, diminished heart rate variability, baroreceptor dysfunction, enhanced lipolysis in visceral fat, increased muscle sympathetic nerve activity, and high urine or plasma catecholamine concentrations as well as turnover rates. The augmented sympathetic activity in individuals with metabolic syndrome worsens prognosis of this high-risk population. The mechanisms linking metabolic syndrome with sympathetic activation are complex and not clearly understood. Whether sympathetic overactivity is involved in the development of the metabolic syndrome or is a consequence of it remains to be elucidated since data from prospective studies are missing. Intervention studies have demonstrated that the autonomic disturbances of the metabolic syndrome may be reversible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Aldo Ferrara, L., Guida, L., Ferrara, F., et al. (2007). Blood pressure at rest, during 24 h monitoring and in response to sympathetic stimulation in hypertensive patients with metabolic syndrome. International Journal of Cardiology, 117, 312–316.

    Article  PubMed  CAS  Google Scholar 

  • Alvarez, G. E., Beske, S. D., Ballard, T. P., & Davy, K. P. (2002). Sympathetic neural activation in visceral obesity. Circulation, 106, 2533–2536.

    Article  PubMed  Google Scholar 

  • Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991). Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. Journal of Clinical Investigation 87, 2246–2252.

    Article  PubMed  CAS  Google Scholar 

  • Aso, Y., Wakabayashi, S., Nakano, T., Yamamoto, R., Takebayashi, K., & Inukai, T. (2006). High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Metabolism 55, 1014–1021.

    Article  PubMed  CAS  Google Scholar 

  • Assmann, G., Guerra, R., Fox, G., et al. (2007). Harmonizing the definition of the metabolic syndrome: Comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. American Journal of Cardiology 99, 541–548.

    Article  PubMed  Google Scholar 

  • Bernardi, L., Ricordi, L., Lazzari, P., et al. (1992). Impaired circardian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation, 86, 1443–1452.

    PubMed  CAS  Google Scholar 

  • Berne, C., Fagius, J., & Niklasson, F. (1989). Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings. Journal of Clinical Investigation, 84, 1403–1409.

    Article  PubMed  CAS  Google Scholar 

  • Berne, C., Fagius, J., Pollare, T., & Hjemdahl, P. (1992). The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia, 35, 873–879.

    Article  PubMed  CAS  Google Scholar 

  • Beske, S. D., Alvarez, G. E., Ballard, T. P., & Davy, K. P. (2002). Reduced cardiovagal baroreflex gain in visceral obesity: Implications for the metabolic syndrome. American Journal of Physiology-Heart and Circulatory Physiology, 282, H630–635.

    PubMed  CAS  Google Scholar 

  • Bianchi, C., Penno, G., Malloggi, L., et al. (2008). Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome. Nutrition Metabolism and Cardiovascular Diseases, 18, 31–38.

    Article  CAS  Google Scholar 

  • Boguszewski, M. C., Johannsson, G., Fortes, L. C., & Sverrisdottir, Y. B. (2004). Low birth size and final height predict high sympathetic nerve activity in adulthood. Journal of Hypertension 22, 1157–1163.

    Article  PubMed  CAS  Google Scholar 

  • Boulton, A. J., Vinik, A. I., Arezzo, J. C., et al. (2005). American Diabetes Association. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 28, 956–962.

    Article  PubMed  Google Scholar 

  • Branth, S., Ronquist, G., Stridsberg, M., et al. (2007). Development of abdominal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress. Nutrition Metabolism and Cardiovascular Diseases, 17, 427–435.

    Article  CAS  Google Scholar 

  • Brunner, E. J., Hemingway, H., Walker, B. R., et al. (2002). Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: Nested case-control study. Circulation 106, 2659–2665.

    Article  PubMed  CAS  Google Scholar 

  • Busetto, L., Digito, M., Dalla Monta, P., Carraro, R., & Enzi, G. (1993). Omental and epigastric adipose tissue lipolytic activity in human obesity. Effect of abdominal fat distribution and relationship with hyperinsulinemia. Hormone and Metabolic Research, 25, 365–371.

    PubMed  CAS  Google Scholar 

  • Chaiken, R. L., & Banerji, M. A. (2006). Metabolic syndrome. In C. S. Mantzoros (Ed.), Obesity and diabetes (pp. 155–168). Totowa, NJ: Humana.

  • Chan, J. L., Mietus, J. E., Raciti, P. M., Goldberger, A. L., & Mantzoros, C. S. (2007). Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans. Clinical Endocrinology (Oxford), 66, 49–57.

    Google Scholar 

  • Chew, G. T., Gan, S. K., & Watts, G. F. (2006). Revisiting the metabolic syndrome. Medical Journal of Australia 185, 445–449.

    PubMed  Google Scholar 

  • Correia, M. L., & Rahmouni, K. (2006). Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obesity & Metabolism, 8, 603–610.

    Article  CAS  Google Scholar 

  • Dalla Pozza, R. D., Bechtold, S., Putzker, S., Bonfig, W., Netz, H., & Schwarz, H. P. (2006). Young adults born small for gestational age: Is reduced baroreceptor sensitivity a risk factor for hypertension? Clinical Cardiology, 29, 215–218.

    Article  PubMed  CAS  Google Scholar 

  • Day, C. (2007). Metabolic syndrome, or What you will: Definitions and epidemiology. Diabetics & Vascular Disease Research, 4, 32–38.

    Article  Google Scholar 

  • DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979). Glucose clamp technique: A method for quantifying insulin secretion and resistance. American Journal of Physiology, 237, E214–223.

    PubMed  CAS  Google Scholar 

  • Ducimetiere, P., Eschwege, E., Papoz, L., Richard, J. L., Claude, J. R., & Rosselin, G. (1980). Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia, 19, 205–210.

    Article  PubMed  CAS  Google Scholar 

  • Emdin, M., Gastaldelli, A., Muscelli, E., et al. (2001). Hyperinsulinemia and autonomic nervous system dysfunction in obesity: Effects of weight loss. Circulation, 103, 513–519.

    PubMed  CAS  Google Scholar 

  • Esler, M., Ferrier, C., Lambert, G., Eisenhofer, G., Cox, H., & Jennings, G. (1991). Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension, 17(Suppl), III29–III35.

    PubMed  CAS  Google Scholar 

  • Fehm, H. L., Kern, W., & Peters, A. (2006). The selfish brain: Competition for energy resources. Progress in Brain Research, 153, 129–140.

    Article  PubMed  CAS  Google Scholar 

  • Ferraro, S., Fazio, S., Santomauro, M., et al. (1990). Cardiac function and sympathetic activity in young diabetics. Diabetes Research and Clinical Practice, 8, 91–99.

    Article  PubMed  CAS  Google Scholar 

  • Frontoni, S., Bracaglia, D., & Gigli, F. (2005). Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes. Nutrition Metabolism and Cardiovascular Diseases, 15, 441–449.

    Article  Google Scholar 

  • Fulop, T., Tessier, D., & Carpentier, A. (2006). The metabolic syndrome. Pathologie Biologie (Paris) 54, 375–386.

    Article  CAS  Google Scholar 

  • Gadegbeku, C. A., Dhandayuthapani, A., Sadler, Z. E., & Egan, B. M. (2002). Raising lipids acutely reduces baroreflex sensitivity. American Journal of Hypertension, 15, 479–485.

    Article  PubMed  CAS  Google Scholar 

  • Galletti, F., Barbato, A., Versiero, M., et al. (2007). Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: An 8-year follow-up study. Journal of Hypertension, 25, 1671–1677.

    Article  PubMed  CAS  Google Scholar 

  • Grassi, G. (1998). Role of the sympathetic nervous system in human hypertension. Journal of Hypertension, 16, 1979–1987.

    Article  PubMed  CAS  Google Scholar 

  • Grassi, G. (2006). Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertension Research, 29, 839–847.

    Article  PubMed  CAS  Google Scholar 

  • Grassi, G., Dell’Oro, R., Facchini, A., Quarti Trevano, F., Bolla, G. B., & Mancia, G. (2004). Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. Journal of Hypertension, 22, 2363–2369.

    Article  PubMed  CAS  Google Scholar 

  • Grassi, G., Dell’Oro, R., Quarti-Trevano, F., et al. (2005). Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia, 48, 1359–1365.

    Article  PubMed  CAS  Google Scholar 

  • Grassi, G., Quarti-Trevano, F., Seravalle, G., & Dell’oro, R. (2007). Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutrition Metabolism and Cardiovascular Diseases, 17, 473–481.

    Article  CAS  Google Scholar 

  • Grassi, G., & Seravalle, G. (2006). Autonomic imbalance and metabolic syndrome: Unravelling interactions, mechanisms and outcomes. Journal of Hypertension, 24, 47–49.

    Article  PubMed  CAS  Google Scholar 

  • Grassi, G., Seravalle, G., Bertinieri, G., et al. (2000). Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly. Journal of Hypertension, 18, 587–593.

    Article  PubMed  CAS  Google Scholar 

  • Hayes, L., Pearce, M. S., & Unwin, N. C. (2006). Lifecourse predictors of normal metabolic parameters in overweight and obese adults. International Journal of Obesity (London), 30, 970–976.

    Article  CAS  Google Scholar 

  • Haynes, W. G. (2000). Interaction between leptin and sympathetic nervous system in hypertension. Current Hypertension Reports, 2, 311–318.

    Article  PubMed  CAS  Google Scholar 

  • Hoffstedt, J., Wahrenberg, H., Thorne, A., & Lonnqvist, F. (1996). The metabolic syndrome is related to beta 3-adrenoceptor sensitivity in visceral adipose tissue. Diabetologia 39, 838–844.

    Article  PubMed  CAS  Google Scholar 

  • Holl, R. W., Pavlovic, M., Heinze, E., & Thon, A. (1999). Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care, 22, 1151–1157.

    Article  PubMed  CAS  Google Scholar 

  • Howard, G., O’Leary, D. H., Zaccaro, D., et al. (1996). Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation, 93, 1809–1817.

    PubMed  CAS  Google Scholar 

  • Huggett, R. J., Burns, J., Mackintosh, A. F., & Mary, D. A. (2004). Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension, 44, 847–852.

    Article  PubMed  CAS  Google Scholar 

  • Ikeda, T., Matsubara, T., Sato, Y., & Sakamoto, N. (1993). Circadian blood pressure variation in diabetic patients with autonomic neuropathy. Journal of Hypertension, 11, 581–587.

    Article  PubMed  CAS  Google Scholar 

  • Iribarren, C., Go, A. S., Husson, G., et al. (2006). Metabolic syndrome and early-onset coronary artery disease: Is the whole greater than its parts? Journal of the American College of Cardiology, 48, 1800–1807.

    Article  PubMed  CAS  Google Scholar 

  • Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005). The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 28, 2289–2304.

    Article  PubMed  Google Scholar 

  • Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. Journal of Clinical Investigation, 106, 473–481.

    Article  PubMed  CAS  Google Scholar 

  • Ko, G. T., Cockram, C. S., Chow, C. C., et al. (2006). Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Research and Clinical Practice, 73, 58–64.

    Article  PubMed  CAS  Google Scholar 

  • Kreier, F., Yilmaz, A., Kalsbeek, A., et al. (2003). Hypothesis: Shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome. Diabetes, 52, 2652–2656.

    Article  PubMed  CAS  Google Scholar 

  • Lembo, G., Napoli, R., Capaldo, B., et al. (1992). Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. Journal of Clinical Investigation, 90, 24–29.

    Article  PubMed  CAS  Google Scholar 

  • Lembo, G., Rendina, V., Iaccarino, G., Lamenza, F., Volpe, M., & Trimarco, B. (1993). Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. Hypertension, 21, 1015–1019.

    PubMed  CAS  Google Scholar 

  • Liao, D., Sloan, R. P., Cascio, W. E., et al. (1998). Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care, 21, 2116–2122.

    Article  PubMed  CAS  Google Scholar 

  • Liatis, S., Tentolouris, N., & Katsilambros, N. (2004). Cardiac autonomic nervous system activity in obesity. Pediatric Endocrinology Review, 1(Suppl 3), 476–483.

    Google Scholar 

  • Lindgren, K., Hagelin, E., Hansen, N., & Lind, L. (2006). Baroreceptor sensitivity is impaired in elderly subjects with metabolic syndrome and insulin resistance. Journal of Hypertension, 24, 143–150.

    Article  PubMed  CAS  Google Scholar 

  • Lopes, H. F., Silva, H. B., Consolim-Colombo, F. M., et al. (2000). Autonomic abnormalities demonstrable in young normotensive subjects who are children of hypertensive parents. Brazilian Journal of Medical and Biological Research, 33, 51–54.

    Article  PubMed  CAS  Google Scholar 

  • Lopes, H. F., Stojiljkovic, M. P., Zhang, D., Goodfriend, T. L., & Egan, B. M. (2001). The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents. American Journal of Hypertension, 14, 1032–1037.

    Article  PubMed  CAS  Google Scholar 

  • Lu, B., Yang, Y., Song, X., et al. (2006). An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism, 55, 1088–1096.

    Article  PubMed  CAS  Google Scholar 

  • Maison, P., Byrne, C. D., Hales, C. N., Day, N. E., & Wareham, N. J. (2001). Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care, 24, 1758–1763.

    Article  PubMed  CAS  Google Scholar 

  • Mancia, G., Bousquet, P., Elghozi, J. L., et al. (2007a). The sympathetic nervous system and the metabolic syndrome. Journal of Hypertension, 25, 909–920.

    PubMed  CAS  Google Scholar 

  • Mancia, G., Bombelli, M., Corrao, G., et al. (2007b). Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: Daily life blood pressure, cardiac damage, and prognosis. Hypertension, 49, 40–47.

    Article  PubMed  CAS  Google Scholar 

  • McNeill, A. M., Rosamond, W. D., Girman, C. J., et al. (2005). The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care, 28, 385–390.

    Article  PubMed  Google Scholar 

  • Meigs, J. B., Wilson, P. W., Nathan, D. M., D’Agostino, R. B., Sr., Williams, K., & Haffner, S. M. (2003). Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes, 52, 2160–2167.

    Article  PubMed  CAS  Google Scholar 

  • Monami, M., Marchionni, N., & Masotti, G., Mannucci, E. (2007). IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients. Diabetes Obesity & Metabolism, 9, 350–353.

    Article  CAS  Google Scholar 

  • Modan, M., & Halkin, H. (1991). Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension. Diabetes Care, 14, 470–487.

    Article  PubMed  CAS  Google Scholar 

  • Morgan, D. A., Balon, T. W., Ginsberg, B. H., & Mark, A. L. (1993). Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. American Journal of Physiology, 264, R423–427.

    PubMed  CAS  Google Scholar 

  • Muntzel, M. S., Morgan, D. A., Mark, A. L., & Johnson, A. K. (1994). Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. American Journal of Physiology, 267, R1350–R1355.

    PubMed  CAS  Google Scholar 

  • Nonogaki, K. (2000). New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia, 43, 533–549.

    Article  PubMed  CAS  Google Scholar 

  • O’Hare, J. A., Minaker, K. L., Meneilly, G. S., Rowe, J. W., Pallotta, J. A., & Young, J. B. (1989). Effect of insulin on plasma norepinephrine and 3,4-dihydroxyphenylalanine in obese men. Metabolism, 38, 322–329.

    Article  PubMed  CAS  Google Scholar 

  • Oda, E. (2006). The metabolic syndrome (emperor) wears no clothes: Response to Kahn. Diabetes Care, 29, 2566.

    Article  PubMed  Google Scholar 

  • Orchard, T. J., Eichner, J., Kuller, L. H., Becker, D. J., McCallum, L. M., & Grandits, G. A. (1994). Insulin as a predictor of coronary heart disease: Interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. Annals of Epidemiology, 4, 40–45.

    Article  PubMed  CAS  Google Scholar 

  • Ostman, J., Arner, P., Engfeldt, P., & Kager, L. (1979). Regional differences in the control of lipolysis in human adipose tissue. Metabolism, 28, 1198–1205.

    Article  PubMed  CAS  Google Scholar 

  • Paolisso, G., Manzella, D., Rizzo, M. R., et al. (2000). Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. American Journal of Clinical Nutrition, 72, 723–730.

    PubMed  CAS  Google Scholar 

  • Perin, P. C., Maule, S., & Quadri, R. (2001). Sympathetic nervous system, diabetes, and hypertension. Clinical and Experimental Hypertension, 23, 45–55.

    Article  PubMed  CAS  Google Scholar 

  • Pikkujamsa, S. M., Huikuri, H. V., Airaksinen, K. E., et al. (1998). Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. American Journal of Hypertension, 11, 523–531.

    Article  PubMed  CAS  Google Scholar 

  • Pyorala, K. (1979). Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care, 2, 131–141.

    Article  PubMed  CAS  Google Scholar 

  • Qiao, Q. (2006). Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia, 49, 2837–2846.

    Article  PubMed  CAS  Google Scholar 

  • Rahmouni, K., & Morgan, D. A. (2007). Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin. Hypertension, 49, 647–652.

    Article  PubMed  CAS  Google Scholar 

  • Rathmann, W., Haastert, B., Icks, A., et al. (2006). Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: The KORA Survey 2000. Diabetes Care, 29, 461.

    Article  PubMed  Google Scholar 

  • Reaven, G. M. (1993). Role of insulin resistance in human disease (syndrome X): An expanded definition. Annual Review of Medicine, 44, 121–131.

    Article  PubMed  CAS  Google Scholar 

  • Reaven, G. M. (2006). The metabolic syndrome: Is this diagnosis necessary? American Journal of Clinical Nutrition, 83, 1237–1247.

    PubMed  CAS  Google Scholar 

  • Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981). Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes, 30, 219–225.

    PubMed  CAS  Google Scholar 

  • Scherrer, U., Randin, D., Tappy, L., Vollenweider, P., Jequier, E., & Nicod, P. (1994). Body fat and sympathetic nerve activity in healthy subjects. Circulation, 89, 2634–2640.

    PubMed  CAS  Google Scholar 

  • Scherrer, U., & Sartori, C. (1997). Insulin as a vascular and sympathoexcitatory hormone: Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation, 96, 4104–4113.

    PubMed  CAS  Google Scholar 

  • Scherrer, U., Vollenweider, P., Randin, D., Jequier, E., Nicod, P., & Tappy, L. (1993). Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation, 88, 388–394.

    PubMed  CAS  Google Scholar 

  • Skrapari, I., Tentolouris, N., Perrea, D., Bakoyiannis, C., Papazafiropoulou, A., & Katsilambros, N. (2007). Baroreflex sensitivity in obesity: Relationship with cardiac autonomic nervous system activity. Obesity (Silver Spring), 15, 1685–1693.

    Article  Google Scholar 

  • Skyler, J. S., Marks, J. B., & Schneiderman, N. (1995). Hypertension in patients with diabetes mellitus. American Journal of Hypertension, 8(12 Pt 2), 100s–105s.

    Article  PubMed  CAS  Google Scholar 

  • Stein, P. K., Barzilay, J. I., Domitrovich, P. P., et al. (2007). The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: The Cardiovascular Health Study. Diabetic Medicine, 24, 855–863.

    Article  PubMed  CAS  Google Scholar 

  • Stern, M. P., Williams, K., Gonzalez-Villalpando, C., Hunt, K. J., & Haffner, S. M. (2004). Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care, 27, 2676–2681.

    Article  PubMed  Google Scholar 

  • Straznicky, N. E., Lambert, E. A., Lambert, G. W., Masuo, K., Esler, M. D., & Nestel, P. J. (2005). Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. The Journal of Clinical Endocrinology and Metabolism, 90, 5998–6005.

    Article  PubMed  CAS  Google Scholar 

  • Straznicky, N. E., Louis, W. J., McGrade, P., & Howes, L. G. (1993). The effects of dietary lipid modification on blood pressure, cardiovascular reactivity and sympathetic activity in man. Journal of Hypertension, 11, 427–437.

    Article  PubMed  CAS  Google Scholar 

  • Sundstrom, J., Vallhagen, E., Riserus, U., et al. (2006). Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care, 29, 1673–1674.

    Article  PubMed  Google Scholar 

  • Tentolouris, N., Liatis, S., & Katsilambros, N. (2006). Sympathetic system activity in obesity and metabolic syndrome. Annals of the New York Academy of Sciences, 1083, 129–152.

    Article  PubMed  CAS  Google Scholar 

  • Tentolouris, N., Tsigos, C., Perea, D., et al. (2003). Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women. Metabolism, 52, 1426–1432.

    Article  PubMed  CAS  Google Scholar 

  • Vollenweider, P., Randin, D., Tappy, L., Jequier, E., Nicod, P., & Scherrer, U. (1994). Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. Journal of Clinical Investigation, 93, 2365–2371.

    Article  PubMed  CAS  Google Scholar 

  • Vollenweider, P., Tappy, L., Randin, D., et al. (1993). Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. Journal of Clinical Investigation, 92, 147–154.

    Article  PubMed  CAS  Google Scholar 

  • Wannamethee, S. G., Shaper, A. G., Lennon, L., & Morris, R. W. (2005). Metabolic syndrome vs. Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Archives of Internal Medicine, 165, 2644–2650.

    Article  PubMed  Google Scholar 

  • Wingard, D. L., Barrett-Connor, E. L., & Ferrara, A. (1995). Is insulin really a heart disease risk factor. Diabetes Care, 18, 1299–1304.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1st Department of Propaedeutic Medicine, Athens University Medical School, Athens, Greece

    Nicholas Tentolouris, Georgia Argyrakopoulou & Nicholas Katsilambros

  2. 33 Lakonias Street, Athens, 115 23, Greece

    Nicholas Tentolouris

Authors
  1. Nicholas Tentolouris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Georgia Argyrakopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicholas Katsilambros
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicholas Tentolouris.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tentolouris, N., Argyrakopoulou, G. & Katsilambros, N. Perturbed Autonomic Nervous System Function in Metabolic Syndrome. Neuromol Med 10, 169–178 (2008). https://doi.org/10.1007/s12017-008-8022-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12017-008-8022-5

Keywords

Search

Navigation